Hypoallergenic mutants of Ole e 1, the major olive pollen allergen, as candidates for allergy vaccines

Clinical and Experimental Allergy

Volumn 37, Issue 2, 2007, Pages 251-260

  Marazuela, E G ^a   Rodriguez R ^a   Barber, D ^b   Villalba, M ^a   Batanero, E ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b ALK ABELLÓ   (Denmark)

Author keywords

Allergy; Hypoallergen; Mouse model; Ole e 1; Olive pollen allergen

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; COMPLEMENTARY DNA; CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1 ANTIBODY; OLE E 1 ANTIGEN; POLLEN ANTIGEN; UNCLASSIFIED DRUG; VACCINE;

ALLERGENICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASH; BASOPHIL; BINDING AFFINITY; CELL ACTIVATION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENGINEERING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGENICITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIVE; PICHIA PASTORIS; POLLEN; POLLEN ALLERGY; PRIORITY JOURNAL; SENSITIZATION; SITE DIRECTED MUTAGENESIS; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ALLERGENS; ANIMALS; ANTIGEN-ANTIBODY REACTIONS; HUMANS; MICE; MODELS, ANIMAL; OLEACEAE; PLANT PROTEINS; RHINITIS, ALLERGIC, SEASONAL; VACCINES, SYNTHETIC;

EID: 33846439330     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2006.02632.x     Document Type: Article

References (50)

1. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001; 1:69-75.
2. Ferreira F, Wallner M, Breiteneder H, Hartl A, Tahlmer J, Ebner C. Genetic engineering of allergens: future therapeutic products. Int Arch Allergy Immunol 2002; 128:171-8.
3. Vrtala S, Focke-Tejkl M, Swoboda I, Kraft D, Valenta R. Strategies for converting allergens into hypoallergenic vaccine candidates. Methods 2004; 32:313-20.
4. Liccardi G, D'Amato M, D'Amato G. Oleaceae pollinosis: a review. Int Arch Allergy Immunol 1996; 111:210-7.
5. Rodríguez R, Villalba M, Monsalve RI, Batanero E. The spectrum of olive pollen allergens. Int Arch Allergy Immunol 2001; 125:185-95.
6. Huecas S, Villalba M, Rodríguez R. Ole e 9, a major olive pollen allergen is a 1,3-beta-glucanase. Isolation, characterization, amino acid sequence, and tissue specificity. J Biol Chem 2001; 276:27959-66.
7. Barral P, Batanero E, Palomares O, Quiralte J, Villalba M, Rodríguez R. A major allergen from pollen defines a novel family of plant proteins and shows intra- and interspecies cross-reactivity. J Immunol 2004; 172:3644-51.
8. Lauzurica P, Gurbindo C, Maruri N et al. Olive (Olea europaea). I. Immunochemical characterization by immunoblotting, CRIE and immunodetection by a monoclonal antibody. Mol Immunol 1988; 25:329-35.
9. Wheeler AW, Hickman BE, Fox B. Heterogeneity of a major allergen from olive (Olea europea) pollen. Mol Immunol 1990; 27:631-6.
10. Van Ree R, Hoffman DR, van Dijk W et al. Lol p XI, a new major grass pollen allergen, is a member of family of soybean trypsin inhibitor-related proteins. J Allergy Clin Immunol 1995; 95:970-8.
11. Calabozo B, Barber D, Polo F. Purification and characterization of the main allergen of Plantago lanceolata pollen, Pla l 1. Clin Exp Allergy 2001; 31:322-30.
12. Barderas R, Villalba M, Lombardero M, Rodríguez R. Identification and characterization of Che a 1 allergen from Chenopodium album pollen. Int Arch Allergy Immunol 2002; 127:47-54.
13. Barderas R, Purohit A, Papanikolaou I, Rodríguez R, Pauli G, Villalba M. Cloning, expression and clinical significance of the major allergen from ash pollen, Fra e 1. J Allergy Clin Immunol 2005; 115:321-7.
14. Batanero E, González de la Peña MA, Villalba M, Monsalve RI, Martín-Estaban M, Rodríguez R. Isolation, cDNA cloning and expression of Lig v 1, the major allergen from privet pollen. Clin Exp Allergy 1996; 26:1401-10.
15. Batanero E, Villalba M, López-Otín C, Rodríguez R. Isolation and characterization of an olive allergen-like protein from lilac pollen. Sequence analysis of three cDNA encoding protein isoforms. Eur J Biochem 1994; 221:187-93.
16. Villalba M, Batanero E, López-Otín C et al. The amino acid sequence of Ole e I, the major allergen from olive tree (Olea europaea) pollen. Eur J Biochem 1993; 216:863-9.
17. Villalba M, Batanero E, Monsalve RI, González de la Peña MA, Lahoz C, Rodríguez R. Cloning and expression of Ole e I, the major allergen from olive tree pollen: polymorphism analysis and tissue specificity. J Biol Chem 1994; 269:15217-22.
18. Huecas S, Villalba M, Gónzalez E, Martínez-Ruiz A, Rodríguez R. Production and detailed characterization of biologically active olive pollen allergen Ole e 1 secreted by the yeast Pichia pastoris. Eur J Biochem 1999; 261:539-45.
19. Quiralte J, González E, Arias de Saavedra JM et al. Immunological activity of recombinant Ole e 1 in patients with Olea europaea pollinosis. Int Arch Allergy Immunol 2000; 122:101-7.
20. Cárdaba B, Del Pozo V, Jurado A et al. Olive pollen allergy: searching for immunodominant T-cell epitopes on the Ole e 1 molecule. Clin Exp Allergy 1998; 28:413-22.
21. González E, Villalba M, Lombardero M, Aalbers M, van Ree R, Rodríguez R. Influence of the 3D-conformation, glycan component and microheterogeneity on the epitope structure of Ole e 1, the major olive allergen. Use of recombinant isoforms and specific monoclonal antibodies as immunological tools. Mol Immunol 2002; 39:93-101.
22. González E, Villalba M, Quiralte J et al. Analysis of IgE and IgG B-cell immunodominant regions of Ole e 1, the main allergen from olive pollen. Mol Immunol 2006; 43:570-8.
23. Vrtala S, Hirtenleher K, Vangelista L et al. Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T-cell epitope-containing fragments. J Clin Invest 1997; 99:1673-81.
24. Ferreira F, Ebner C, Kramer B et al. Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J 1998; 12:231-42.
25. Holm J, Gajhede M, Ferreras M et al. Allergy vaccine engineering: epitope modulation of recombinant Bet v 1 reduces IgE-binding but retains protein folding pattern for induction of protective blocking-antibody responses. J Immunol 2004; 173:5258-67.
26. Takai T, Yokota T, Yasue N et al. Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy. Nature Biotechnology 1997; 15:754-8.
27. Drew AC, Eusebius NP, Kenins L et al. Hypoallergenic variants of the major latex allergen Hev b 6.01 retaining human T lymphocyte reactivity. J Immunol 2004; 173:5872-89.
28. Swoboda I, de Weerd N, Bhalla PL et al. Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy. Eur J Biochem 2002; 32:295-302.
29. Orlandi A, Grasso F, Corinti S et al. The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization. Clin Exp Allergy 2004; 34:470-7.
30. Schramm G, Kahlert H, Suck R et al. Allergen engineering: variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T-cell reactivity. J Immunol 1999; 162:2406-14.
31. Westritschnig K, Focke M, Verdino P et al. Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p7. J Immunol 2004; 172:5684-92.
32. Lombardero M, Quirce S, Duffort O et al. Monoclonal antibodies against Olea europaea major allergen: allergenic activity of affinity-purified allergen and depleted extract and development of a radioimmunoassay for the quantification of the allergen. J Allergy Clin Immunol 1992; 89:884-94.
33. Van Ree R, Aalbers M, Kea O et al. A sensitive monoclonal antibody sandwich ELISA for the measurement of the major olive pollen allergen Ole e 1. Int Arch Allergy Immunol 2000; 122:224-8.
34. Batanero E, Villalba M, Ledesma A, Puente XS, Rodríguez R. Ole e 3, an olive-tree allergen, belongs to a widespread family of pollen proteins. Eur J Biochem 1996; 241:772-8.
35. Laemmeli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75.
37. Barderas R, Villalba M, Rodríguez R. Che a 1: recombinant expression, purification and equivalence with the natural form. Int Arch Allergy Immunol 2004; 135:284-92.
38. Batanero E, Barral P, Villalba M, Rodríguez R. Sensitization of mice with olive pollen allergen Ole e 1 induces a Th2 response. Int Arch Allergy Immunol 2002; 127:269-75.
39. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4.
40. Hoffmann A, Vieths S, Haustin D. Biological allergen assay for in vivo test allergens with an in vitro model of the murine type I reactions. J Allergy Clin Immunol 1997; 99:227-32.
41. Mothes N, Horak F, Valenta R. Transition from botanical to a molecular classification in tree pollen allergy: implications for diagnosis and therapy. Int Arch Allergy Immunol 2004; 135:357-73.
42. Van Regenmortel MHV. Which structural features determine protein antigenicity? Trends Biol Sci 1986; 11:36-9.
43. Rabjohn P, West CM, Connaughton C et al. Modification of peanut allergen Ara h 3: effects on IgE-binding and T-cell stimulation. Int Arch Allergy Immunol 2002; 128:15-23.
44. Karisola P, Mikkola J, Kalkkinen N et al. Construction of hevein (Hev b 6.02) with reduced allergenicity for immunotherapy of latex by commutation of six acid residues on the conformational IgE epitopes. J Immunol 2004; 172:2621-8.
45. Vrtala S, Akdis CA, Budak F et al. T-cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies. J Immunol 2000; 165:6653-9.
46. Till SJ, Francis JN, Nouri-Aria K, Durham SR. Mechanism of immunotherapy. J Allergy Clin Immunol 2004; 113:1025-34.
47. +T cells by inhibiting serum-IgE-facilitated allergen presentation. J Immunol 1999; 163:2944-52.
48. Wachholz PA, Soni NK, Till SJ, Durham SR. Inhibition of allergen-IgE-binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol 2003; 112:915-22.
49. Ball T, Fuchs T, Sperr WR et al. B cell epitopes of themajor timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidate for immunotherapy. FASEB J 1999; 13:1277-90.
50. Herz U, Renz H, Wiedermann U. Animal models of type I allergy using recombinant allergens. Methods 2004; 32:271-80.